mit media lab digital currency initiative Top Overview

Flying Pig: In 2024, the number of holiday businesses whose GMV exceeded 100 million yuan was three times that of last year. On December 12, Flying Pig said at the 2024 holiday business conference that under the positioning of the open platform, the business efficiency and business satisfaction of businesses continued to improve. In 2024, the number of travel agencies, amusement parks, cruise ships and other holiday businesses on the Flying Pig platform maintained double-digit growth year-on-year. The number of businesses with GMV exceeding 100 million yuan was three times that of last year, and the average order volume of gold medal merchants reached more than twice the market level, with a conversion rate about 20% higher.The Nikkei 225 index just broke through the 39,900.00 mark, and the latest report was 39,899.07, up 1.34% in the day.India imported 841,993 tons of palm oil in November, compared with 845,682 tons in October.

Huachuang Securities: It was first rated as "recommended" by Zangge Mining, with a target price of 33.3 yuan. Huachuang Securities Research Report pointed out that Zangge Mining (000408.SZ) is an important producer of potassium lithium salt and copper in China, with a high dividend return to shareholders. The company actively arranges high-quality potash resources at home and abroad: three major projects, namely, Heibei potash mine in Dalangtan, Alkali-Shishan potash mine and the eastern part of deep brine potash mine in Xiaoliangshan-Dafengshan area, are steadily promoted in China, with a total exploration right of 1,400 square kilometers; Overseas has signed a potash exploration agreement with Laos. At present, the exploration report and potash mine reserve certificate have been obtained. It is estimated that the total amount of potassium chloride resources in Setani County and Ba 'e County is 984 million tons. It is estimated that the output of the first phase of potassium chloride project will be 1 million tons/year, and the scale of potassium chloride production is expected to double in the future. The company is an important manufacturer of potassium and lithium in China, and Julong Copper is expected to inject strong kinetic energy into the company's growth. Considering that Mamicho Mining has not been consolidated at present, it is estimated that the company will realize a net profit of 25.0/27.7/4.29 billion yuan in 24-26 years, which is -27%, +11% and +54.9% respectively. In 2025, it can be compared with the company's average valuation of 19 times, giving the company a valuation of 19 times in 2025, corresponding to the target price of 33.3 yuan, covering for the first time and giving a "recommended" rating.The Japanese yen faces new risks. Strategists worry that the Bank of Japan may wait until March or later to raise interest rates. A new risk is emerging for the Japanese yen. Foreign exchange strategists in Tokyo warn that the Bank of Japan may wait until March or later next year to raise interest rates. On Wednesday, the market tasted this danger, and the yen fell to its lowest level in more than two weeks as traders responded to a Bloomberg report that the Bank of Japan is known to think that it is no harm to raise interest rates later. The yen only fell to 152.82 against the dollar, and the market is still debating whether the Bank of Japan will take action at its next meeting on December 19 or about a month later. Shusuke Yamada, head of Japan's foreign exchange and interest rate strategy at Bank of America in Tokyo, said that if policymakers put off raising interest rates for a longer time, the situation would be very different. "If the interest rate hike is postponed until March, the yen carry trade is likely to make a comeback," Yamada said on Thursday. "The yen is likely to fall again to a level just below the 157 mark hit in 155 or November."Foreign investors bought 556.2 billion yen of Japanese stocks and stock index futures last week, the highest level in the past four weeks. According to the weekly trading data released by the Japan Exchange Group, foreign investors bought a total of 556.2 billion yen of Japanese stocks and stock index futures in the week ending December 6, the highest level since November 8.

Guangxi: In November, 23,774 cases of legal infectious diseases were reported and 320 people died. The Health and Health Commission of Guangxi Zhuang Autonomous Region announced the epidemic situation of legal infectious diseases in Guangxi in November 2024. No cases of Class A infectious diseases were reported. 14,775 cases of Class B infectious diseases were reported, with 320 deaths. The reported diseases include AIDS, viral hepatitis, rabies, dengue fever, dysentery, tuberculosis, typhoid plus paratyphoid, whooping cough, scarlet fever, brucellosis, gonorrhea, syphilis, leptospirosis, malaria, novel coronavirus infection and monkeypox. The top five reported cases were viral hepatitis, tuberculosis, syphilis, AIDS and gonorrhea, accounting for 94.34% in total. 8999 cases of Class C infectious diseases were reported, with no death. The reported diseases include influenza, mumps, rubella, acute hemorrhagic conjunctivitis, leprosy, typhus, other infectious diarrhea and hand, foot and mouth disease. The top three reported cases were other infectious diarrhea, hand-foot-mouth disease and influenza, accounting for 91.43% in total.In the first ten months, Jiangsu's ship exports exceeded 60%, ranking first in the country. According to Nanjing Customs statistics, from January to October this year, Jiangsu exported 85.84 billion yuan of all kinds of ships, ranking first in the country in terms of export scale, with a year-on-year increase of 63.2%. The exports of three main ship types, namely, tankers, container ships and bulk carriers, increased by 179.5%, 91% and 16.2% respectively.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).